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PPARg coactivator 1a (PGC-1a) is a potent
stimulator of mitochondrial biogenesis and
respiration. Since the mitochondrial electron
transport chain is the main producer of reactive
oxygen species (ROS) in most cells, we exam-
ined the effect of PGC-1a on the metabolism
of ROS. PGC-1a is coinduced with several key
ROS-detoxifying enzymes upon treatment of
cells with an oxidative stressor; studies with
RNAi or null cells indicate that PGC-1a is
required for the induction of many ROS-detox-
ifying enzymes, including GPx1 and SOD2.
PGC-1a null mice are much more sensitive to
the neurodegenerative effects of MPTP and
kainic acid, oxidative stressors affecting the
substantia nigra and hippocampus, respec-
tively. Increasing PGC-1a levels dramatically
protects neural cells in culture from oxidative-
stressor-mediated death. These studies reveal
that PGC-1a is a broad and powerful regulator
of ROSmetabolism, providing a potential target
for the therapeutic manipulation of these im-
portant endogenous toxins.
INTRODUCTION
Mitochondria are the powerhouse of the cell, providing
most of the ATP for cellular reactions. ATP production in
mitochondria is coupled to an electron transport systemin which the passage of electrons down the various elec-
tron carriers is associated with the transport of protons
from the matrix into the intermembrane space. The major-
ity of these protons reenter the mitochondrial matrix by the
ATP synthase, thereby generating ATP. However, approx-
imately 20% of mitochondrial oxygen consumption is not
coupled to ATP production, and protons enter the matrix
through the phospholipid bilayer and the uncoupling pro-
teins, generating heat (Rolfe and Brown, 1997).
Mitochondrial metabolism is also responsible for the
majority of the reactive oxygen species (ROS) production
in cells (Balaban et al., 2005). The formation of ROS occurs
when unpaired electrons escape the electron transport
chain and react with molecular oxygen, generating super-
oxide. Superoxide can react with DNA, proteins, and lipids
and plays an important role in many physiological and
pathophysiological conditions, notably ischemia-reperfu-
sion injury, neurodegenerative diseases, and aging (Bala-
ban et al., 2005). ROS can also react with NO, generating
reactive nitrogen species (RNS) (Brown and Borutaite,
2001). The maintenance of low ROS levels is critical to nor-
mal cell functions, and therefore, prolonged increases in
mitochondrial activity carry an inherent risk of increasing
ROS levels.
The first line of defense against ROS is the detoxifying
enzymes that scavenge ROS. These include the super-
oxide dismutases (SODs) and catalase. Since some
ROS can diffuse throughout the cell, ROS-detoxifying
enzymes are found in mitochondria, cytoplasm, and
peroxisomes. Another line of defense that limits ROS
production by mitochondria is the uncoupling proteins
(Arsenijevic et al., 2000; Echtay et al., 2002). Uncoupling
decreases ROS generation by decreasing the electro-
chemical potential across the inner mitochondrialCell 127, 397–408, October 20, 2006 ª2006 Elsevier Inc. 397
membrane, which shortens the half-life of the most reac-
tive steps in the electron transport chain (Brand, 2000).
PGC-1a has emerged as a master regulator of mitochon-
drial biogenesis and respiration (Kelly and Scarpulla,
2004; Lehman et al., 2000; Lin et al., 2002; Puigserver
et al., 1998; Wu et al., 1999). PGC-1a is a transcriptional
coactivator that transduces many physiological stimuli
into specific metabolic programs, often by stimulating
mitochondrial activity. For example, PGC-1a regulates
adaptive thermogenesis in brown adipose tissue (BAT)
(Puigserver et al., 1998), fiber-type switching in skeletal
muscle (Lin et al., 2002), and both b-oxidation of fatty
acids and gluconeogenesis in liver (Herzig et al., 2001;
Puigserver et al., 2003; Rhee et al., 2003; Yoon et al.,
2001).
The activation of mitochondrial biogenesis by PGC-1a
results from the coactivation of ERRa, NRF-1, and NRF-
2 (Mootha et al., 2004; Wu et al., 1999). The importance
of PGC-1a in these metabolic programs was further
revealed through the generation of PGC-1a null mice.
These mice display a reduced basal expression of
many mitochondrial genes in liver, brain, skeletal muscle,
and heart compared with wild-type (WT) animals (Arany
et al., 2005; Leone et al., 2005; Lin et al., 2004). In addi-
tion, the capacity of the heart to perform basal and stren-
uous aerobic work is compromised in the mutant mice
(Arany et al., 2005; Leone et al., 2005). These mice are
also extremely cold sensitive, illustrating the absolute re-
quirement for PGC-1a in adaptive thermogenesis. Lastly,
and unexpectedly, PGC-1a knockout (KO) mice uncov-
ered an important role for PGC-1a in brain structure
and function: These animals displayed neurodegenera-
tive lesions in the brain, particularly in the striatum, and
also showed behavioral abnormalities (Leone et al.,
2005; Lin et al., 2004). At present, the cause of the brain
lesions is unclear, but the brain lesions observed in many
genetic models with altered ROS levels raise the possibil-
ity that PGC-1a plays an important role in the control of
ROS in vivo.
The role of PGC-1a in ROS metabolism has remained
largely unexplored. The increase in mitochondrial number
stimulated by this protein could, in principle, cause an in-
crease in the production of ROS. In accordance with the
fact that PGC-1a stimulates a broad program of mito-
chondrial gene expression, we and others have reported
that the expression of mitochondrial ROS-detoxifying
enzymes increases with PGC-1a (Kukidome et al.,
2006; St-Pierre et al., 2003; Valle et al., 2005). However,
the effect of PGC-1a in broader systems of cellular ROS
metabolism was not known. In this paper, we show that
PGC-1a is part of a homeostatic cycle that is central to
the control of ROS. PGC-1a and PGC-1b are powerfully
induced by ROS, and these coactivators, in turn, regulate
a complex and multifaceted ROS defense system. Fur-
thermore, PGC-1a KO mice have a greatly increased
sensitivity to damage by oxidative stress in the dopami-
nergic cells of the substantia nigra and hippocampal
neurons.398 Cell 127, 397–408, October 20, 2006 ª2006 Elsevier Inc.RESULTS
PGC-1a and PGC-1b Are Increased upon Oxidative
Stress and Regulate Components of the ROS
Defense System
To determine whether PGC-1a and PGC-1b (Lin et al.,
2005a) play a role in the metabolism of ROS, we examined
their expression in 10T1/2 cells after treatment with a clas-
sic oxidative stressor, hydrogen peroxide (H2O2). H2O2 is
the product of the dismutation of superoxide and is also
a precursor to hydroxyl radicals. As expected, this oxida-
tive stress induced the genes of the ROS defense system
(Mates et al., 1999), encoding copper/zinc superoxide dis-
mutase (SOD1), manganese SOD (SOD2), catalase, and
glutathione peroxidase (GPx1) (Figure 1). Notably, the
expression of PGC-1a and PGC-1b was also increased
significantly upon H2O2 treatment. The increase in PGC-
1a expression (6-fold) was consistently larger than that
for PGC-1b (2.5-fold; Figure 1). In addition, the expression
of the uncouplers UCP2 and UCP3 and adenine nucleo-
tide translocator 1 (ANT1) was elevated upon oxidative
stress. Coregulation of PGC-1a, PGC-1b, and multiple
components of the cytoplasmic and mitochondrial ROS
defense system suggests that these transcriptional co-
activators could play a role in the regulation of the ROS
metabolic gene program.
To assess whether PGC-1a regulates the expression of
the ROS defense system, 10T1/2 cells were infected with
adenovirus expressing RNAi against PGC-1a (Herzig
et al., 2001) or a scrambled RNA sequence. RNAi against
PGC-1a reduced basal PGC-1amRNA levels by 52% and
also reduced the baseline expression of mRNA encoding
the ROS-detoxifying enzymes SOD1, SOD2, catalase,
and GPx1 (Figure 1A). This RNAi also reduced the induc-
tion of PGC-1a mRNA by H2O2 by approximately 75%
and substantially reduced the induction of mRNA encod-
ing cytochrome c, UCP2, UCP3, ANT1, SOD1, SOD2,
and GPx1 by at least 75%; catalasemRNA was unaffected
(Figure 1A). Interestingly, RNAi against PGC-1a did not
change the baseline expression of PGC-1b but blunted
its induction upon H2O2 treatment, suggesting that
PGC-1a regulates PGC-1b mRNA under these conditions
(Figure 1A). We next examined the role of PGC-1b in reg-
ulating the expression of these anti-ROS components.
Cells expressing PGC-1b RNAi (Lin et al., 2005b) dis-
played a higher basal expression of PGC-1a and a super-
induction of PGC-1a in the presence of H2O2 compared
with cells expressing the scrambled RNA (Figure 1B).
The expression of UCP2 and UCP3 followed the same
pattern as that of PGC-1a (Figure 1B). The expression of
ANT1, SOD1, SOD2, catalase, and GPx1 was similar in
cells expressing PGC-1b RNAi and those expressing
scrambled RNA both in the presence and in the absence
of H2O2 (Figure 1B).
Cells were then coinfected with viruses expressing
RNAi directed against both PGC-1a and PGC-1b. Viral
levels were equivalent in all samples. The expression
of UCP2, UCP3, and ANT1 as well as that of all the
Figure 1. PGC-1a and PGC-1b Regulate Genes of the ROS Defense System
(A) 10T1/2 cells were infected with RNAi against PGC-1a or with scrambled controls. After 3 days, cells were treated with 1 mM H2O2 for 2 hr followed
by a recovery period of 2 hr. Cells were then harvested for RNA isolation, and relative expression of PGC-1s and uncouplers as well as mitochondrial,
cytoplasmic, and peroxisomal ROS-detoxifying enzymes was measured by real-time PCR. In this and all other figures, error bars represent means ±
SEM. n = 3.
(B) 10T1/2 cells were infected with RNAi against PGC-1b or with scrambled controls. Cells were treated and analyzed as described above.
(C) 10T1/2 cells were infected with RNAi against both PGC-1a and PGC-1b or with scrambled controls. Cells were treated and analyzed as described
above.
(D) The relative expression of various components of the ROS defense system were determined by real-time PCR analysis in the brain of PGC-1a null
mice compared with WT controls. n = 3–4. * denotes statistical significance compared with WT controls.ROS-detoxifying enzymes’ mRNA (SOD1, SOD2, GPx1,
and catalase) was reduced by approximately half in cells
expressing PGC-1a and PGC-1b RNAi compared with
those expressing scrambled RNA (Figure 1C). Further-
more, the induction of UCP3, ANT1, and all the ROS-
detoxifying enzymes in response to H2O2 was essentially
abolished in cells expressing PGC-1a and PGC-1b RNAi
(Figure 1C). In fact, the expression of several of the com-
ponents of the ROS defense system in these cells was
even decreased below basal levels after H2O2 treatment,
indicating that they could not respond at all to the oxida-
tive insult. The superinduction of UCP2 after H2O2 treat-
ment in cells expressing PGC-1a and PGC-1b RNAi illus-
trates clearly that other factors can regulate this uncoupler
during an oxidative challenge (Figure 1C). Together, these
data show that PGC-1a and PGC-1b play a key role in reg-
ulating the basal expression level of multiple components
of the ROS defense system and are required for the induc-tion of the anti-ROS gene program upon this oxidative
challenge.
We then examined the basal expression level of the
ROS defense system in two tissues known to be particu-
larly sensitive to oxidative stress, heart and brain. The
basal mRNA expression level of cytoplasmic SOD1, mito-
chondrial SOD2, and peroxisomal catalase was consider-
ably reduced in heart and brain of PGC-1a null mice com-
pared with WT mice (Figure 1D; see also Figure S1 in the
Supplemental Data available with this article online). How-
ever, the expression ofGPx1 remained unchanged in both
heart and brain of PGC-1a null mice. The expression of
UCP2 and UCP3 was also unchanged in PGC-1a null
mice, while the expression of ANT1 was lowered in the
brain but not in the heart. As expected (Lin et al., 2004),
the expression of cytochrome c was reduced in the heart
and brain of the PGC-1a null mice compared with WT
animals (Figure 1D; Figure S1). The PGC-1a null cells stillCell 127, 397–408, October 20, 2006 ª2006 Elsevier Inc. 399
Figure 2. PGC-1a Null Cells Have a Reduced ROS Defense System
(A) Fibroblasts derived from PGC-1a null (KO) mice and WT controls were treated with 200 mM H2O2 for 2 hr followed by 2 hr recovery. Cells were then
harvested and analyzed for relative expression of various cDNAs using real-time PCR analysis. n = 3–5. * denotes statistical significance.
(B) Cells derived from WT and PGC-1a KO mice as well as PGC-1a KO cells stably expressing RNAi directed against PGC-1b were treated with
increasing concentrations of H2O2. After 6 hr of treatment, survival was quantified as the percentage of live cells using an LDH-based cytotoxicity
detection kit. n = 3.
(C) The intracellular ROS levels of cells derived from WT and PGC-1a KO mice were determined using the fluorescent dye CM-H2DCFDA. ROS levels
were quantified by flow cytometry. n = 3. * denotes statistical significance compared with WT controls.
(D) Representative flow cytometry analysis curve for quantification of ROS levels in WT and PGC-1a KO-derived cells.express a nonfunctional mRNA containing exon 2 of the
PGC-1a gene (Lin et al., 2004), and PGC-1a exon 2 ex-
pression was slightly upregulated in both tissues.
PGC-1a Null Cells Display a Blunted Induction
of the ROS Defense System and Are More
Sensitive to Oxidative Stress
We have also examined the response to H2O2 in brown-fat
fibroblasts genetically deficient in PGC-1a (Uldry et al.,
2006). The basal mRNA expression of most of the compo-
nents of the ROS defense system was similar in the cells
from the PGC-1a null mice and WT controls; the expres-
sion of UCP2 mRNA was reduced by half in the PGC-1a
null fibroblasts (Figure 2A). After treatment with H2O2,
the expression of PGC-1a as well as the components of
the ROS defense system was increased in WT fibroblasts.
In contrast, the mRNA induction of the components of the
ROS defense system was reduced in the PGC-1a null
cells. Specifically, there was a significantly decreased in-400 Cell 127, 397–408, October 20, 2006 ª2006 Elsevier Inc.duction for UCP2, SOD2, catalase, and GPx1 (Figure 2A).
UCP1 was induced similarly in WT and PGC-1a null fibro-
blasts after treatment with H2O2 (data not shown).
To further study the role of the PGC-1s in providing de-
fense against oxidative stress, WT fibroblasts, PGC-1a
null fibroblasts, and PGC-1a null fibroblasts stably ex-
pressing RNAi directed against PGC-1b were analyzed
for H2O2-induced cell death. Approximately half of the
PGC-1a null cells died after exposure to 1.5 mM H2O2,
while only 25% of the WT fibroblasts died (Figure 2B). Fur-
thermore, under 1.5 mM H2O2, more than 80% death oc-
curs in cells lacking both PGC-1s (Figure 2B). Consistent
with these changes, thePGC-1a null cells had significantly
higher intracellular levels of ROS than WT fibroblasts did,
as indicated by an increased fluorescence in the presence
of the compound DFCDA (Figures 2C and 2D).
Consistent with the increased ROS levels in these cells,
the relative expression of PGC-1a exon 2 in PGC-1a null
cells was increased by almost 2-fold compared to control
Figure 3. The PGC-1a Promoter Is Regulated by CREB in the Presence of H2O2
(A) 10T1/2 cells were transfected with the 2 kb PGC-1a promoter linked to a luciferase reporter gene harboring no mutations (2 kb) or mutated at the
MEF, NRF2, or FOXO3A sites. Cells were treated with vehicle or 1 mM H2O2, and luciferase activity was measured 24 hr after transfection. The
luciferase activity was normalized to the level of b-galactosidase and to the activity of an empty pGL3basic reporter gene vector. n = 4.
(B) 10T1/2 cells were transfected with the 2 kb PGC-1a promoter linked to a luciferase reporter gene harboring no mutations (2 kb) or a CRE site
deletion (2 kb CRED) in the presence or absence of vector expressing dominant-negative CREB (CREB DN). As a control, pGL3basic (empty vector)
was transfected. Cells were treated and analyzed as described in (A).
(C) Electrophoretic mobility shift assays were performed with nuclear extracts from 10T1/2 cells treated with or without 1 mM H2O2 for 16 hr and radio-
labeled probe encoding the CRE-binding site from the PGC-1a promoter. Antibodies against CREB were used to test the specificity of the interaction.
(D) Chromatin immunoprecipitation was performed with nuclear extracts from 10T1/2 cells treated with or without H2O2 for 4 and 16 hr. Antibody
against phospho-CREB was used to precipitate DNA/protein complexes. Specific primers encompassing the CRE-binding site in the PGC-1a pro-
moter were used to analyze specific binding to the promoter.
(E) 10T1/2 cells were treated with or without 1 mM H2O2 for 2 hr followed by 2 hr recovery or treated with 1 mM H2O2 for 16 hr without recovery. Cell
lysates were then analyzed using immunoblotting analysis to test for CREB and phosphorylated CREB protein levels. Expression of a-tubulin was
used as loading control.cells (Figure 2A, PGC-1a). These data indicate that PGC-
1a null fibroblasts have reduced expression of the anti-
ROS genetic program, a higher steady-state level of
ROS, and a greater sensitivity to oxidative stress.
Involvement of CREB in the Regulation
of the PGC-1a Promoter by H2O2
We sought to determine which transcription factors are
involved in the induction of PGC-1a mRNA in response
to H2O2 treatment. Using the Genomatix analysis
(http://www.genomatix.de), we examined the first 2 kb
of the PGC-1a promoter for binding sites of transcriptionfactors known to play a role during oxidative stress. We
focused our effort on the sites that bind the transcrip-
tion factors Cre-binding protein (CREB) (Bedogni et al.,
2003), forkhead box O3A (FOXO3A) (Nemoto and Finkel,
2002), and NFE-related factor 2 (NRF2) (Lee et al., 2005).
The activity of the PGC-1a promoter was increased ap-
proximately 4-fold in the presence of H2O2 (Figures 3A
and 3B). The promoters with a mutation in the FOXO3A,
MAD box transcription enhancer factor (MEF), or NRF2
sites displayed the same activity as the control promoter
in the absence or presence of H2O2 (Figure 3A). In con-
trast, the PGC-1a promoter with a mutation in the CRECell 127, 397–408, October 20, 2006 ª2006 Elsevier Inc. 401
Figure 4. PGC-1a Null Mice Have Greater Dopaminergic Cell Death in Response to the Neurotoxin MPTP
(A) WT and PGC-1a null (KO) mice were injected with either MPTP or control saline. After 3 days, mice were deeply anesthetized, and brain tissue
was fixed by cardiac perfusion and paraffin embedded. Brain sections taken through the substantia nigra were analyzed for tyrosine hydroxylase
(TH)-positive cells, shown in brown.
(B) Tyrosine hydroxylase-positive neurons in the substantia nigra (in brown) of WT andPGC-1aKO mice treated with MPTP. Magnification of the lower
panels in (A) is shown.site had reduction in basal activity and reduced induction
upon H2O2 treatment (Figure 3B). In addition, transfection
of the dominant-negative allele of CREB (Ahn et al., 1998)
reduced the basal activity of the control PGC-1a promoter
and almost completely suppressed the induction by H2O2
treatment (Figure 3B). These data strongly suggest that
CREB plays an important role in the regulation of the
PGC-1a promoter upon H2O2 treatment.
CREB has been found to be an important regulator of
PGC-1a expression under normal physiological stimuli
(Handschin et al., 2003; Herzig et al., 2001). Upon H2O2
treatment, there was a quantitative increase in the major
protein complex binding to a CRE-containing oligonucle-
otide (Figure 3C); this binding was reduced by an antibody
against CREB, and a small amount of a supershifted band
appeared. Immunoblots with antibodies against total
CREB or phospho-CREB (phosphoserine 133) showed
a large increase in total CREB protein after 4 hr of H2O2
treatment (Figure 3E), and a smaller increase could also
be observed after 16 hr of treatment. Importantly, there
was also a large increase in phospho-CREB at both times
(Figure 3E). Finally, Figure 3D demonstrates very clearly by
chromatin immunoprecipitation that the binding of phos-
phorylated CREB to the PGC-1a promoter increases dur-
ing oxidative stress in cells.
Increased Sensitivity to Oxidative Stress
in the Brain of PGC-1a KO Mice
To test whether the PGC-1a null mice have an increased
sensitivity to oxidative stress, we injected PGC-1a null
mice and littermate WT mice with 1-methyl-4-phenyl-
1,2,3,6-tetrahydropyridine (MPTP). This neurotoxin is
widely used to model Parkinson’s disease (PD) in rodents402 Cell 127, 397–408, October 20, 2006 ª2006 Elsevier Inc.and primates (Przedborski et al., 2004; Singer and Ram-
say, 1990). Its mechanisms of action include inhibition of
the electron transport chain at complex I, resulting in a bio-
energetic crisis and ROS activation, which leads to selec-
tive death of dopaminergic neurons in the substantia nigra
pars compacta.
At baseline, WT and KO 6-week-old male mice had
similar numbers of dopaminergic neurons, identified by ty-
rosine hydroxylase (TH) immunoreactivity (Figure 4A and
Figure 5A). In contrast, acute MPTP treatment with a sub-
maximal dose (see Experimental Procedures) caused a
61% reduction in the number of TH-positive neurons in
KO mice but only a 12% reduction in WT mice (Figure 4
and Figure 5A).
To ask whether this cell death was associated with in-
creased oxidative stress, we stained equivalent brain sec-
tions with antibodies against nitrosylated proteins. Protein
nitrosylation at tyrosine is a stable modification subse-
quent to reaction of superoxide with nitric oxide to form
the very reactive peroxynitrite. As shown in Figure 5B,
the substantia nigra of the PGC-1a KO mice had much
more intense staining for nitrotyrosine after MPTP treat-
ment compared with sections from the control mice.
These data indicate that, in mice lacking PGC-1a, the
greatly increased neurodegeneration due to MPTP treat-
ment is associated with excessive oxidative damage.
We also challenged these mice with another oxidative
stressor, kainic acid (KA). KA is a glutamate receptor ago-
nist that induces excitotoxicity in the hippocampus as a
result of epileptic seizures. The KA damage/excitotoxic
cell death is associated with the formation of ROS and ox-
idative damage (Wang et al., 2005). Baseline histology of
the hippocampus of the PGC-1a null mice was normal
Figure 5. Excessive Oxidative Damage Caused by MPTP in the PGC-1a Null Mice
(A) Quantification of tyrosine hydroxylase-positive neurons in the substantia nigra of WT and PGC-1a null (KO) mice treated with MPTP. n = 4.
(B) Brain sections taken through the substantia nigra were analyzed for nitrosylated protein expression as a marker for ROS-induced cell damage,
using anti-nitrotyrosine (shown in brown).despite the typical vacuolar pathology seen in the striatum
(Figure S2A). Three days following status epilepticus, his-
topathological analysis of the entire brain showed pathol-
ogy that was limited to CA1 neurons of the hippocampus.
CA1 neurons appeared intensely hypereosinophilic with
extensive clumping of chromatin (Figures 6A and 6B), par-
ticularly in the KO mice compared to the WT animals. Also,
the CA1 subfield neurons displayed increased TUNEL-
positive staining (Figure 6C), which specifically labels cells
that are apoptotic. This was associated with greatly in-
creased oxidative damage, as observed by increased
labeling of cells with an antibody against 8-oxoguanine
(Figure 6D). In contrast, all WT mice showed less extensive
damage (Figures 6B–6D), while the vehicle-treated cohort
showed no evidence of such pathology (data not shown).
Together these data illustrate, using two different models
of neuronal challenge, that the brain ofPGC-1a null mice is
more sensitive to neurodegeneration and ROS-mediated
damage than that of WT controls.PGC-1a Protects WT Neural Cells
against Oxidative Stress
It was important to ask whether an increased level of PGC-
1a has a protective effect on cultured neural cells against
ROS-mediated cell death. PGC-1a was expressed in mu-
rine neuronal progenitor cells from the striatum; these
cells were treated for 24 hr with increasing concentrations
of paraquat, a compound that generates superoxide, or
with H2O2. The levels ofPGC-1amRNA achieved were ap-
proximately 40-fold higher than those observed in whole
mouse brain (data not shown). Since PGC-1a is expressed
in a very site-selective manner in the brain, it is likely that
the overexpression is much less relative to cells from
certain centers such as the striatum and substantia nigra.
As can be seen in Figure 7, the striatal cells expressing
PGC-1a ectopically were strongly protected against death
caused by paraquat or H2O2 compared with GFP-
expressing control cells. Indeed, at the highest concen-
trations of paraquat and H2O2 tested, PGC-1a causedCell 127, 397–408, October 20, 2006 ª2006 Elsevier Inc. 403
Figure 6. PGC-1a Null Mice Display Increased Oxidative Damage in CA1 Neurons Following Kainic-Acid Treatment
PGC-1a null (KO) mice show more severe disorganization of CA1 neurons, characterized by chromatin clumping (hematoxylin) and hypereosinophilic
cytoplasm (A and B), which are characteristic of excitotoxic injury following status epilepticus. This typical histopathological profile is accompanied by
increased TUNEL-positive neurons in the KO mice (C) as well as increased labeling with the oxidative-stress marker 8-oxoguanine (D).a powerful increase in the survival of cells, from 45% to
70% (paraquat) and from 49% to 79% (H2O2), compared
to control cells. In separate experiments, PGC-1a also
had a protective effect against H2O2-mediated cells death
in human SH-SY5Y neuroblastoma cells. Indeed, SH-
SY5Y cells stably transfected with PGC-1a displayed
a greater than 100% increase in survival after 24 hr of
treatment with 20 mM H2O2 compared with control cells
(Figure S3).
The relative expression levels for mRNAs encoding sev-
eral mitochondrial and nonmitochondrial ROS-detoxifying
enzymes were examined in the striatal cells expressing
PGC-1a and controls. At all time points examined (0, 12,
and 24 hr), elevated PGC-1a expression paralleled in-
creased expression levels of mRNA for several ROS-de-
toxifying enzymes, namely SOD2, SOD1, GPx1, and
UCP2, compared with GFP control cells (Figure 7C). The
expression of catalase did not differ between GFP and
PGC-1a-infected cells at these time points (Figure 7C).
We also observed a small but significant increase in the
expression of PGC-1a mRNA in GFP cells treated with
paraquat for 24 hr compared with untreated cells (data
not shown). This increase was accompanied by a modest
increase in the expression of cytochrome c and SOD1 as
well as by a considerable increase in the expression of
catalase (Figure 7C). These results clearly demonstrate
that PGC-1a can protect WT neural cells from oxidative
stress and that this protection is correlated with an in-
creased expression of ROS-detoxifying genes.
DISCUSSION
The PGC-1 coactivators are major, perhaps the major,
regulators of mitochondrial biogenesis in response to404 Cell 127, 397–408, October 20, 2006 ª2006 Elsevier Inc.changing conditions external to the cell or organism (Lin
et al., 2005a). Therefore, if ROS production were propor-
tional to the increase in electron transport activity stimu-
lated by the PGC-1 proteins, these molecules would
ultimately drive ROS levels higher. Two previous pieces
of data suggested that this is not necessarily true. First,
cold exposure and exercise are not normally associated
with the deleterious effects of ROS in BAT and muscle, re-
spectively. On the contrary, physical activity and exercise
are associated with fewer ROS-related changes. Second,
PGC-1a has been shown to increase the expression of
a major antioxidant enzyme of mitochondria, SOD2 (Kuki-
dome et al., 2006; St-Pierre et al., 2003; Valle et al., 2005).
However, the physiological significance of these results
was ambiguous since this coactivator increases the ex-
pression of most if not all mitochondrial proteins and
thus increases expression of proteins that promote ROS
formation, as well as those that suppress it. The data pre-
sented in this study show unambiguously that the PGC-
1s, especially PGC-1a, are powerful suppressors of
ROS. Indeed, the classic induction of the ROS-scaveng-
ing enzymes by an oxidative stressor requires PGC-1a.
Importantly, the induction of anti-ROS genes is not limited
to those of the mitochondria: GPx1, catalase, and SOD1
are all present substantially or totally in the nonmitochon-
drial cytoplasm and peroxisomes. Also key is the fact that
PGC-1a can regulate the expression of UCP2 and UCP3,
both of which are now understood to be important regula-
tors of ROS formation (Brand, 2000). Nevertheless, we ob-
served that the expression of UCP2 and UCP3 did not al-
ways parallel that of PGC-1a; this is likely a reflection of
the fact that the UCPs play other roles apart from reducing
ROS, notably in the regulation of the metabolism of fatty
acids (Brand, 2000).
Figure 7. PGC-1a Protects Neuronal Progenitor Striatal Cells from Oxidative Insults
(A–C) Striatal cells infected with GFP or PGC-1a adenovirus were treated for 24 hr with increasing concentrations of paraquat (A) or H2O2 (B) prior to
viability assessment. Oxidative gene expression was evaluated by real-time PCR at 12 and 24 hr of paraquat (1.5 mM) treatment (C). n = 3. * denotes
statistical significance between PGC-1a and GFP-infected cells.
(D) Schematic presentation of the ROS regulation cycle, mediated through PGC-1a induction. The expression of PGC-1a is increased by physiolog-
ical stimuli such as cold in brown fat or exercise in muscle, leading to mitochondrial biogenesis and increased respiration. Simultaneously, PGC-1a
initiates an anti-ROS program that prevents a rise in intracellular ROS levels. PGC-1a can also be induced by ROS and plays a key role in the ROS
homeostatic cycle.That PGC-1a possesses dual activities—stimulating
mitochondrial electron transport while suppressing ROS
levels—provides a clear mechanism whereby tissues
such as skeletal muscle, brown fat, and others can ramp
up mitochondrial metabolism to deal with altered external
conditions without causing self-inflicted oxidative damage
(Figure 7D). Since alterations in rates of oxidative metab-
olism are such a fundamental aspect of life on earth, it is
(at least in retrospect) not surprising that mechanisms in-
creasing mitochondrial activity are so tightly linked to an
anti-ROS genetic program. From the perspective of inte-
grative physiological systems, the data presented in this
paper suggest that PGC-1a may serve as an adaptive
set-point regulator, capable of providing an accurate
balance between metabolic requirements and cytotoxic
protection from the ensuing consequences of increased
ROS activation.ROS-related damage has been implicated in aging,
cancer, and ischemia-reperfusion injury of the heart and
brain (Balaban et al., 2005; Wallace, 1999). However, we
have focused initially on two neurodegenerative condi-
tions since the connections between neurodegeneration
and ROS are very strong (Beal, 2005; Schapira, 1998)
and because there are well-established experimental sys-
tems to study these (Bove et al., 2005). MPTP-induced
Parkinsonism has been unambiguously associated with
oxidative damage to the substantia nigra (Przedborski
et al., 2000; Singer and Ramsay, 1990). Similarly, seizures
induced by kainic acid have been associated with oxida-
tive damage in the hippocampus (Wang et al., 2005).
The absence of PGC-1a again renders the brain more sen-
sitive to neurodegeneration, with apoptotic cell death and
increased oxidative damage. While it is not possible yet to
conclude that the loss of the anti-ROS activity of PGC-1aCell 127, 397–408, October 20, 2006 ª2006 Elsevier Inc. 405
is the sole cause of the neurodegeneration seen in both of
these degenerative brain models, it is extremely likely that
it is at least an important contributing factor. Interestingly,
CREB KO mice display progressive neurodegeneration in
the hippocampal and striatal neurons (Mantamadiotis
et al., 2002), and PGC-1a could act downstream of
CREB to promote neuronal survival.
The apparent ability of PGC-1a to increase mitochon-
drial electron transport activity while stimulating a broad
anti-ROS program makes this an almost ideal protein to
control or limit the damage that has been associated
with defective mitochondrial function seen in neurodegen-
erative diseases such as Parkinson’s, Alzheimer’s, and
Huntington’s diseases. Increasing levels of a given protein
in the brain is not necessarily a simple task, but the fact
that PGC-1a is a highly inducible factor in most tissues
and responds to common pathways of calcium and cyclic
AMP signaling strongly suggests that it will be possible to
find drugs that induce PGC-1a in the brain. This could
represent a new mode of therapy for a set of diseases
that are common and have only marginal therapies at
this moment.
EXPERIMENTAL PROCEDURES
Plasmids and Reagents
The 2 kb PGC-1a promoter construct has been described previously
(Handschin et al., 2003). The dominant-negative CREB allele was
kindly provided by Charles Vinson (National Cancer Institute, National
Institutes of Health) (Ahn et al., 1998). Antibodies against CREB for
western blots were generously provided by Michael Greenberg (Korn-
hauser et al., 2002), while antibodies against CREB for gel-shift assays
were purchased from Santa Cruz. The antibodies against phosphory-
lated CREB and tubulin were from Cell Signaling and Santa Cruz, re-
spectively. The PGC-1a RNAi adenovirus was a kind gift from Marc
Montminy (Koo et al., 2004), while the PGC-1b RNAi was from Lin
et al. (2005b). The H2O2 solution and all other reagents were from
Sigma unless otherwise stated.
Cell Culture and Adenoviral Infections
10T1/2 cells were maintained in DMEM supplemented with 10% fetal
bovine serum (FBS). For the experiments using adenoviruses, cells
were infected for 24 hr, and the relative gene expression of the ROS-
detoxifying system was determined 72 hr after infection.
Real-Time PCR
Real-time PCR analyses were performed as described in Handschin
et al. (2003). The cDNA synthesis step included a control reaction with-
out the reverse transcriptase, and the PCR step included a control
reaction without the template to rule out contamination or genomic
amplification. In addition, the TATA-box binding protein (TBP) gene
was used as a control to account for possible variations in initial
RNA quantity or efficiency of the cDNA synthesis reaction. Sequences
for real-time PCR primers are available in the Supplemental Data.
Measurement of ROS Levels
The intracellular ROS levels of cells derived from WT and PGC-1a null
mice were determined using CM-H2DCFDA (Molecular Probes). For
these experiments, cells were incubated with phosphate-buffered sa-
line (PBS) and 5 mM CM-H2DCFDA. As a negative control, cells were
incubated with PBS and vehicle (DMSO). As a positive control, cells
were incubated with PBS, 5 mM CM-H2DCFDA, and 50 mM H2O2. After
a 30 min incubation period, cells were trypsinized, washed, and resus-406 Cell 127, 397–408, October 20, 2006 ª2006 Elsevier Inc.pended in PBS. The levels of fluorescence were immediately detected
using flow cytometry.
Cell Survival Measurements
The resistance to H2O2 of fibroblast cells derived from WT and PGC-1a
null mice was quantified as the percentage of live cells after a 6 hr treat-
ment with various concentrations of H2O2. The quantitation of dead
cells upon H2O2 treatment was carried out using the Cytotoxicity
Detection Kit (LDH) from Roche. Since the product of the biochemical
reaction is red, the cells were incubated in DMEM without phenol red
supplemented with 10% FBS to avoid colorimetric interference.
We also determined the resistance of two types of neural cells to ox-
idative stress, namely SH-SY5Y human neuroblastoma cells and neu-
ral progenitor striatal cells. The SH-SY5Y human neuroblastoma cells
were stably transfected with mouse PGC-1a and vector control using
the Lipofectamine transfection kit (Invitrogen), with selection by puro-
mycin resistance. We tested four separately treated cultures for each
condition. Cells were plated in 60 mm Petri dishes at 50,000 cells
per dish and exposed to H2O2 or control media for 24 hr. Cells were
then rinsed in PBS, and surviving (adherent) cells were lysed with
0.5% Triton X-100. LDH concentration was measured in the lysate
using the CytoTox 96 nonradioactive cytotoxicity assay (Promega).
The neural progenitor striatal cells were treated for 24 hr with increas-
ing concentrations of paraquat or H2O2 prior to viability assessment
using the Cytotoxicity Detection Kit (LDH) from Roche.
Treatment of Mice with MPTP
PCG-1a WT and null mice were generated as described before. Six-
week-old male mice were injected intraperitoneally (10 mg/kg i.p. ev-
ery 2 hours, four times) with either MPTP or saline control (n = 4). After
3 days, mice were deeply anesthetized, and brain tissue was fixed by
cardiac perfusion with 4% paraformaldehyde (PFA), paraffin embed-
ded, and processed for routine H&E and immunohistochemical (IHC)
analysis. For anti-nitrotyrosine staining, 4% PFA-fixed brains were de-
hydrated in 25% sucrose (0.1 M PBS) overnight and then sectioned
(40 mm) with a cryostat. All subsequent staining steps were performed
on free-floating sections before mounting on slides. All experiments
were performed in accordance with Dana-Farber Cancer Institute
and National Institutes of Health guidelines on the ethical use of
animals.
Kainic-Acid-Induced Seizure
To induce seizures, both WT (n = 4) and KO (n = 4) mice were injected
i.p. with 15 mg/kg KA; i.p. saline injections were used as control (n = 4)
for the treatment. All mice were age (3–4 months) and sex (male)
matched. This dose of KA caused seizures in all mice, with no mortal-
ity. All animals were observed for a period of 2 hr for seizure behavior
and were scored according to the Racine score: 1, staring and head
nodding; 2, unilateral forelimb clonus; 3, bilateral forelimb clonus; 4,
bilateral clonus with rearing, falling backward, and loss of balance
(generalized seizure, status epilepticus). The latency to onset of sei-
zure behaviors, duration, and intensity were monitored.
All mice were deeply anesthetized and transcardially perfused with
ice-cold saline followed by 4% paraformaldehyde in 0.1 M PBS (pH
7.4). The brains were removed and processed for histological and
immunohistochemical analyses as described above. We used rabbit
anti-nitrotyrosine (NITT) 1:100 (Alpha Diagnostic) and mouse anti-
8-oxoguanine 1:100 (Chemicon) as oxidative stress markers. DNA
fragmentation analysis (apoptosis) was performed by TUNEL staining
(Oncogene). TUNEL-positive cells were stained dark brown, while nor-
mal cells were counterstained with hematoxylin. Surviving neurons
and TUNEL-positive cells were averaged from counts of adjacent sec-
tions extending through the entire hippocampus. DNA fragmentation
analysis was performed using a terminal deoxynucleotidyl transferase
(TdT)-mediated dUTP nick end labeling (TUNEL assay, Oncogene).
TUNEL-positive cells stain dark brown, while normal cells are blue.
Surviving neurons were averaged from counts on adjacent brain
sections through the entire hippocampus. Two KO mice (and no con-
trols) showed severe neurodegeneration; the data shown here are from
one of the severely affected KOs.
Supplemental Data
Supplemental Data include Supplemental Experimental Procedures
and three figures and can be found with this article online at http://
www.cell.com/cgi/content/full/127/2/397/DC1/.
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